Implementation of a Clinical Screening and Response System for Cardiac Complications After Noncardiac Surgery
Implementation of a Clinical Screening and Response System for the Early Detection of Cardiac Complications After Noncardiac Surgery: Feasibility and Medicoeconomic Impact
University Hospital, Basel, Switzerland
900 participants
Jul 1, 2021
OBSERVATIONAL
Conditions
Summary
The investigators aim to show the feasibility and medicoeconomic impact of implementing a clinical screening and response system for the early detection of perioperative cardiac complications in high-risk patients. Specifically, the investigators aim to: 1) evaluate the feasibility of implementation of a PMI-screening; 2) evaluate the medicoeconomic impact of implementing a PMI-screening; 3) identify barriers to implementation; 4) generate data for a future randomized controlled trial on outcomes by exploring opportunities to improve care following PMI, the occurrence and timing of major adverse cardiac events (MACE), and the treatment effect associated with PMI-screening.
Eligibility
Inclusion Criteria6
- Consecutive patients fulfilling the institutional criteria for inclusion into the routine PMI-screening
- aged 40-85 years
- at increased cardiovascular risk
- undergoing inpatient, noncardiac, elective or emergent surgery
- postoperative stay of ≥2 nights at the participating institution
- orthopaedic, traumatology, vascular, spinal, thoracic, neurosurgical, and visceral surgery.
Exclusion Criteria6
- patients with cardiac surgery or interventions in the last 14 days
- chronic renal failure under dialysis, renal transplant surgery
- moderate-to-severe dementia
- previous inclusion within 5 days
- documented refusal to use of their data for research purposes or refusal of further use during follow-up
- Patients declining consent for follow-up will be excluded from follow-up analyses.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
There is no study-specific intervention. The investigators will record data generated by clinical activity before, during and after implementation of the PMI-screening. Follow-up data and the final PMI event adjudication will be the only data generated specifically for this study.
Locations(5)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05859620